DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Kang YK. et al.
Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial.
Ann Oncol 2009;
20: 666-673
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.